Vaibhav Rajoriya

Prof. Dr. Vaibhav Rajoriya

Shri Rawatpura Sarkar College, Sagar, MP, Indian Trail, North Carolina, USA
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2024 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
Vaibhav RajoriyaVaibhav Rajoriya
Vaibhav Rajoriya
RGRavikant Gupta
Ravikant Gupta
SVSudha Vengurlekar
Sudha Vengurlekar
USUpama Surendra Singh
Upama Surendra Singh

4 July 2017 in Analytical Chemistry Letters
Verified
Journal Article
Closed access
Vaibhav RajoriyaVaibhav Rajoriya
Vaibhav Rajoriya
VKVarsha Kashaw
Varsha Kashaw
A RP-HPLC method was developed and validated for concurrent estimation of nebivolol hydrochloride (NEB) and valsartan (VAL) in a combination (5 mg: 80 mg (w/w) Byvalson TM). An RP-HPLC analysis was carried on Shimadzu LC-20AT series HPLC; C-18 ODS bonded column (25 cm × 4.60 mm, 10 μl, 40°C) used as stationary phase; potassium hydrogen phosphate buffer: acetonitrile: methanol (15:50:35v/v/v) was used as mobile phase. The retention time of the NEB and VAL were 2.930 and 4.780 min, respectively; detection carried out at λmax 273 nm for both of drug (overlain spectra). Linear regression analysis shows a good linear relationship; in the concentration range of 2.5-7.5 μg/ml and 48-112 μg/ml; for NEB and VAL with r > 0.999 and 0.997 respectively. The method was statistically validated with a relative standard deviation of less than 2% indicating high degree of accuracy and precision. Hence proposed method can be successfully applied for the simultaneous estimation of Nebivolol and Valsartan in marketed formulation. This method was successfully applied for reliable quantification of NEB and VAL in commercial and routine analysis in combined dosage form.

4 December 2013 in Journal of Nanoparticle Research
Verified
Journal Article
Closed access
PDF file
NJNivrati Jain
Nivrati Jain
Vaibhav RajoriyaVaibhav Rajoriya
Vaibhav Rajoriya
PJPrateek Jain
Prateek Jain
AJAshish Kumar Jain
Ashish Kumar Jain

31 January 2025 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
Vaibhav RajoriyaVaibhav Rajoriya
Vaibhav Rajoriya
RGRavikant Gupta
Ravikant Gupta
SVSudha Vengurlekar
Sudha Vengurlekar
SJSachin Kumar Jain
Sachin Kumar Jain

1 July 2021 in Current Nanomedicine
Verified
Journal Article
Closed access
PDF file
SRSwati Rathore
Swati Rathore
Vaibhav RajoriyaVaibhav Rajoriya
Vaibhav Rajoriya
VKVarun Kushwah
Varun Kushwah
SJSanyog Jain
Sanyog Jain
SKSushil Kashaw
Sushil Kashaw
Objective: The present study aimed to explore the in-vitro anticancer potential of 5-fluorouracil (5-FU) loaded PLGA nanogels coated with nerolidol sesquiterpene. Methods: The emulsification-solvent evaporation technique was used for the preparation of plain PLGA nanogels (PNGs) and 5-FU loaded PLGA nanogels (FPNGs). A surface coating of Nerolidol (2%) sesquiterpene was employed to improve the penetration efficacy of the nanogels into the stratum corneum. Results: The nanogels formulation FPNGs have the size range 220±0.25% nm obtained by dynamic light scattering. The entrapment efficiency of approx ~ 42% with a sustained-release pattern for 24 h was estimated at different pH ranges. The cell uptake and localization profile were revealed by confocal microscopy analysis using the HaCaT cell line. MTT assay demonstrated the cell compatibility of nanogels, confirmed by apoptosis assay depicting the apoptotic index of 0.87. Conclusion: This study concludes that FPNGs are a promising nanogels system against skin cancer that can be used to boost the chemo-therapeutic efficiency of bioactives with sustained and controlled release at the desired site.

26 August 2025 in BioNanoScience
Verified
Journal Article
Closed access
PDF file
Vaibhav RajoriyaVaibhav Rajoriya
Vaibhav Rajoriya
RGRavikant Gupta
Ravikant Gupta